SBI-087
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SBI-087, covering 2013-12-03 to 2024-08-14. Get the full timeline:
Most recent: Clinical Trial Update: Study Evaluating Single Doses Of SBI-087 In Japanese Subjects With Rheumatoid Arthritis [Phase 1]